Allergan PLC Agrees To Pay $750 Million To Settle Namenda Antitrust Suit

In 2015, Plaintiffs filed a First Amended Class Action Complaint on behalf of a proposed class of direct purchasers of branded and generic Namenda, a drug used to treat moderate-to-severe Alzheimer’s, alleging a two-pronged scheme on the part of Defendants to impair generic competition, including a “reverse payment” agreement to delay generic entry, and the […]

Read More

Judge Cites Dr. Lamb’s Analysis in Certifying Class of Indirect Purchasers of Branded or Generic Lovenox

In 2017, Plaintiffs filed an Amended Complaint on behalf of a proposed class of indirect purchasers of Lovenox, and/or its generic equivalent enoxaparin, alleging an agreement among Defendants to monopolize sales of enoxaparin and prevent competition by controlling patented technology used to establish sameness for purposes of obtaining FDA approval to market generic enoxaparin.  Counsel […]

Read More

Monument’s Cynthia Jones Judges Preliminary Round of CFA Institute’s Global Investment Research Challenge

This year’s Global Investment Research Challenge is underway, including more than 5,700 participants from 1,100 universities worldwide. This annual event, which is sponsored globally by the CFA Institute and is hosted by local CFA chapters, saw the largest number of New York-area participants ever, with more than 30 university-sponsored teams submitting reports and presenting to […]

Read More